Depo-testosterone and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Depo-testosterone (testosterone cypionate) and Mobic (meloxicam). Common drug interactions include abdominal discomfort among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Depo-testosterone and Mobic. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Depo-testosterone?

Depo-testosterone has active ingredients of testosterone cypionate. It is often used in low testosterone. eHealthMe is studying from 4,295 Depo-testosterone users. Check the latest studies of Depo-testosterone.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

18 people who take Depo-testosterone and Mobic together, and have interactions are studied.

Depo-testosterone and Mobic drug interactions.

What are the common drug interactions of Depo-Testosterone and Mobic, by gender? *:

female:

Abdominal discomfort
Anxiety disorder
Blood pressure increased
Borderline personality disorder
Depression
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Heart rate increased
Hyperlipidaemia (presence of excess lipids in the blood)
Hypertension (high blood pressure)

male:

Depression
Emotional distress
Mobility decreased (ability to move is reduced)
Muscle mass
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Syncope (loss of consciousness with an inability to maintain postural tone)
Anxiety
Injection site swelling
Renal failure (kidney dysfunction)
Hypoacusis (loss of hearing)

What are the common drug interactions of Depo-Testosterone and Mobic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Injection site swelling
Gastric cancer (stomach cancer)
Neuroendocrine tumour (a tumour that forms from cells that release hormones into the blood in response to a signal from the nervous system)

50-59:

Asthenia (weakness)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Mobility decreased (ability to move is reduced)
Muscle mass
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Syncope (loss of consciousness with an inability to maintain postural tone)
Chronic kidney disease
Renal failure (kidney dysfunction)
Hypoacusis (loss of hearing)
Abdominal discomfort

60+:

Pulmonary embolism (blockage of the main artery of the lung)
Abdominal discomfort
Hypertension (high blood pressure)
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Panic attack
Weight decreased
Abdominal pain
Constipation
Dizziness

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 61.11%
Depression: 10 people, 55.56%
High Blood Pressure: 9 people, 50.00%
High Blood Cholesterol: 8 people, 44.44%
Pain: 6 people, 33.33%
Diabetes: 5 people, 27.78%
Headache (pain in head): 4 people, 22.22%
Joint Pain: 4 people, 22.22%
Stress And Anxiety: 4 people, 22.22%
Plantar Fasciitis (painful inflammatory process of the plantar fascia): 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-testosterone and Mobic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously